Unraveling clonal hematopoiesis of indeterminate potential (CHIP) in cancer: Prevalence, clonal dynamics, and prognostic significance.


Por: González, AP, Jou, CP, Acha, P, Navarro, V, Palomo, L, Calvete, O, Baraibar, I, Gonzalez, NS, Zamora, E, Sanz, L, Fariñas-Madrid, L, Brana, I, Gonzalez, M, Ristol, F, Diez-Campelo, M, Alfonso-Pierola, A, Bosch, F, Montoro, J and Valcárcel, D

Publicada: 1 jun 2025
Resumen:


Filiaciones:
Univ Hosp Vall dHebron, Vall dHebron Inst Oncol VHIO, Dept Hematol, Barcelona, Spain
Vall dHebron Inst Oncol VHIO, Stat Unit, Barcelona, Spain
Hosp Badalona Germans Trias & Pujol, Inst Catala Oncol ICO, Hematol Dept, Barcelona, Spain
Inst Recerca Leucemia Josep Carreras, Badalona, Spain
Vall dHebron Univ Hosp, Vall dHebron Inst Oncol VHIO, Dept Med Oncol, Barcelona, Spain
Salamanca IBSAL Univ Hosp, Dept Hematol, Salamanca, Spain
Clin Univ Navarra, Ctr Invest Biomed Red Canc, Dept Oncol Hematol,CIBERONC, Ctr Invest Med Aplicada CIMA,Navarra Univ IDISNA, Pamplona, Spain
ISSN: 0732183X





JOURNAL OF CLINICAL ONCOLOGY
Editorial
American Society of Clinical Oncology, 2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA, Estados Unidos America
Tipo de documento: Meeting Abstract
Volumen: 43 Número: 16_SUPPL
Páginas: 22524-22524
WOS Id: 001690271200025

MÉTRICAS